Daya C Wijesuriya

Title: Daya C Wijesuriya: Innovator in Immunoassay Technology

Introduction

Daya C Wijesuriya is a notable inventor based in Parkinson, Australia. She has made significant contributions to the field of immunoassays, particularly in enhancing the accuracy of diagnostic tests. Her innovative approach addresses common challenges faced in immunochromatographic assays.

Latest Patents

Daya holds a patent for her invention titled "Use of dual conjugated labels in the elimination of serum interference in immunochromatographic assays." This patent describes a method and device designed to improve the reliability of immunoassays. The invention focuses on preventing non-analyte specific binding of heterophilic antibodies to labeled antibodies, which can lead to inaccurate measurements of analytes. By adding immunoglobulin from the same animal source as the labeled antibody, Daya's method effectively reduces non-specific binding. Additionally, her invention incorporates a specific binding pair, such as biotin/avidin or fluorescein/anti-fluorescein, to enhance the assay's performance.

Career Highlights

Daya is currently employed at Bayer Healthcare LLC, where she continues to develop innovative solutions in the healthcare sector. Her work has been instrumental in advancing diagnostic technologies, making significant impacts on patient care and treatment outcomes.

Collaborations

Throughout her career, Daya has collaborated with esteemed colleagues, including Lloyd S Schulman and Ronald G Sommer. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of immunoassays.

Conclusion

Daya C Wijesuriya's contributions to immunoassay technology exemplify her commitment to innovation and excellence. Her patented methods not only enhance the accuracy of diagnostic tests but also pave the way for future advancements in the field.